CN1270719C - 利用局部皮质类固醇治疗包茎的药物组合物 - Google Patents

利用局部皮质类固醇治疗包茎的药物组合物 Download PDF

Info

Publication number
CN1270719C
CN1270719C CNB01822296XA CN01822296A CN1270719C CN 1270719 C CN1270719 C CN 1270719C CN B01822296X A CNB01822296X A CN B01822296XA CN 01822296 A CN01822296 A CN 01822296A CN 1270719 C CN1270719 C CN 1270719C
Authority
CN
China
Prior art keywords
pharmaceutical composition
purposes
described pharmaceutical
phimosis
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB01822296XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1487833A (zh
Inventor
P·C·罗德李古斯帕尔玛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apsen Farmaceutica SA
Original Assignee
Apsen Farmaceutica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apsen Farmaceutica SA filed Critical Apsen Farmaceutica SA
Publication of CN1487833A publication Critical patent/CN1487833A/zh
Application granted granted Critical
Publication of CN1270719C publication Critical patent/CN1270719C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB01822296XA 2000-12-28 2001-12-13 利用局部皮质类固醇治疗包茎的药物组合物 Expired - Fee Related CN1270719C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI00065560 2000-12-28
BR0006556-0A BR0006556A (pt) 2000-12-28 2000-12-28 Composição farmacêutica para uso tópico à base de corticosteróide para tratamento de fimose

Publications (2)

Publication Number Publication Date
CN1487833A CN1487833A (zh) 2004-04-07
CN1270719C true CN1270719C (zh) 2006-08-23

Family

ID=36686652

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB01822296XA Expired - Fee Related CN1270719C (zh) 2000-12-28 2001-12-13 利用局部皮质类固醇治疗包茎的药物组合物

Country Status (12)

Country Link
US (1) US7666858B2 (enExample)
EP (1) EP1365766B1 (enExample)
JP (1) JP5095907B2 (enExample)
CN (1) CN1270719C (enExample)
AR (1) AR032208A1 (enExample)
AU (1) AU2002221365A1 (enExample)
BR (1) BR0006556A (enExample)
DE (1) DE60121047T2 (enExample)
ES (1) ES2267671T3 (enExample)
MX (1) MXPA03005813A (enExample)
RU (1) RU2279893C2 (enExample)
WO (1) WO2002053137A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070134232A1 (en) * 2005-12-14 2007-06-14 Joel Studin Topical bite care composition
US20070225670A1 (en) * 2006-03-14 2007-09-27 Connell Thomas J Diapers for improving male genital health and methods of using the same
ES2441961T3 (es) * 2007-02-15 2014-02-07 Allergan, Inc. Composiciones de toxina botulínica y métodos
IN2013CN00342A (enExample) * 2010-06-17 2015-07-03 Nitto Denko Corp
DK2595624T3 (en) * 2010-07-20 2018-03-26 Halozyme Inc Methods of treating or preventing adverse side effects associated with administration of an anti-hyaluronan agent
CN102302779A (zh) * 2011-07-29 2012-01-04 岳中瑾 治疗包茎的乳膏制剂及其应用
RU2569431C2 (ru) * 2013-07-08 2015-11-27 Александр Васильевич Газаматов Способ консервативного лечения фимоза
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN110314168A (zh) * 2019-07-27 2019-10-11 清远市人民医院 一种用于治疗小儿包茎的药物组合物及其制备方法
RU2730476C1 (ru) * 2019-12-24 2020-08-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Противовоспалительная мазь для животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2058780C1 (ru) * 1992-11-17 1996-04-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы

Also Published As

Publication number Publication date
JP5095907B2 (ja) 2012-12-12
EP1365766B1 (en) 2006-06-21
US7666858B2 (en) 2010-02-23
RU2279893C2 (ru) 2006-07-20
RU2003119439A (ru) 2005-02-27
HK1060850A1 (en) 2004-08-27
AR032208A1 (es) 2003-10-29
CN1487833A (zh) 2004-04-07
EP1365766A2 (en) 2003-12-03
AU2002221365A1 (en) 2002-07-16
WO2002053137A2 (en) 2002-07-11
BR0006556A (pt) 2002-09-17
ES2267671T3 (es) 2007-03-16
DE60121047D1 (de) 2006-08-03
JP2004519451A (ja) 2004-07-02
US20040067922A1 (en) 2004-04-08
WO2002053137A3 (en) 2003-04-24
MXPA03005813A (es) 2005-02-14
DE60121047T2 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
Eisen et al. Number V Oral lichen planus: clinical features and management
Buajeeb et al. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus
CN104144679A (zh) 用于治疗人类炎症性疾病的脂质体皮质类固醇
Cohen et al. Linear IgA disease histopathologically and clinically masquerading as lichen planus
EP1365766B1 (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
JP3507439B2 (ja) 排尿障害治療剤
Hasan et al. Evaluation of 5% amlexenox oral paste and rebamipide tablets in treatment of recurrent apthous stomatitis and comparison with dologel CT
McAleer et al. Infantile pyoderma gangrenosum
CN1627948A (zh) 治疗炎症性肠病的组合物和试剂盒
Suresh et al. Successful treatment of mucous membrane pemphigoid with tacrolimus
HK1060850B (en) Pharmaceutical composition for treatment of phimosis using topical corticosteroid
Moy et al. Cicatricial pemphigoid: A case of onset at age 5
JP2000229884A (ja) 皮膚外用剤
Sanjay et al. Clinical study comparing herbal plant extract as a supportive treatment for chronic periodontitis
Aguirre et al. Desquamative gingivitis
El Araby et al. Mucoadhesive mycophenolate mofetil and injectable platelet rich fibrin in the treatment of oral lichen planus
BINDRA et al. Dexamethasone Induced Perineal Pruritus in Patients Undergoing Minor Oral Surgical Procedures-A Prospective Cohort Study.
US20140249118A1 (en) Treatment of oral lichen planus with a combination of triamcinolone and retinoic acid
Verdy et al. Effect of methandrostenolone on blood lipids and liver function tests
Swathi et al. Erosive Oral Lichen Planus-A Case Report
Moccia et al. Review of oral psoriasis
Peker et al. Localized oral mucous membrane pemphigoid: Successful treatment with intralesional triamcinolone acetonide injection
Dev et al. Primary complex aphthosis responding well to dapsone
Piskorz Rare Syndromes Related to Acne and Hidradenitis Suppurativa
Madhavan et al. Knowledge on Rebamipide a novel agent used for the treatment of recurrent aphthous ulcer-A Review.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1060850

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060823

Termination date: 20131213